ATE454399T1 - Assays für den präimplantationsfaktor und präimplantationsfaktorpeptide - Google Patents

Assays für den präimplantationsfaktor und präimplantationsfaktorpeptide

Info

Publication number
ATE454399T1
ATE454399T1 AT02749703T AT02749703T ATE454399T1 AT E454399 T1 ATE454399 T1 AT E454399T1 AT 02749703 T AT02749703 T AT 02749703T AT 02749703 T AT02749703 T AT 02749703T AT E454399 T1 ATE454399 T1 AT E454399T1
Authority
AT
Austria
Prior art keywords
pif
present
flow cytometry
assay
binding
Prior art date
Application number
AT02749703T
Other languages
German (de)
English (en)
Inventor
Eytan Barnea
Ruben Renee Gonzalez Perez
Paul Leavis
Original Assignee
Bioincept Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioincept Llc filed Critical Bioincept Llc
Application granted granted Critical
Publication of ATE454399T1 publication Critical patent/ATE454399T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70507—C2D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02749703T 2001-07-02 2002-06-28 Assays für den präimplantationsfaktor und präimplantationsfaktorpeptide ATE454399T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30260701P 2001-07-02 2001-07-02
PCT/US2002/020599 WO2003004601A2 (en) 2001-07-02 2002-06-28 New assays for preimplantation factor and preimplantation factor peptides

Publications (1)

Publication Number Publication Date
ATE454399T1 true ATE454399T1 (de) 2010-01-15

Family

ID=23168483

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02749703T ATE454399T1 (de) 2001-07-02 2002-06-28 Assays für den präimplantationsfaktor und präimplantationsfaktorpeptide

Country Status (12)

Country Link
US (8) US7273708B2 (https=)
EP (1) EP1404877B1 (https=)
JP (1) JP4593106B2 (https=)
CN (5) CN101059510A (https=)
AT (1) ATE454399T1 (https=)
AU (1) AU2002320198B2 (https=)
CA (1) CA2490538C (https=)
DE (1) DE60235011D1 (https=)
IL (6) IL159671A0 (https=)
MX (1) MXPA04000151A (https=)
NZ (1) NZ530723A (https=)
WO (1) WO2003004601A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8222211B2 (en) * 2001-07-02 2012-07-17 Bioincept, Llc Methods of administering PIF agonist peptides and uses thereof
US7273708B2 (en) * 2001-07-02 2007-09-25 Bioincept, Llc Assays for preimplantation factor and preimplantation factor peptides
US7723290B2 (en) * 2004-10-22 2010-05-25 Bioincept, Llc Compositions and methods for modulating the immune system
EP1680442B1 (en) * 2003-10-22 2011-07-13 Bioincept, LLC. Pif peptides biologic activities
WO2005040196A2 (en) 2003-10-22 2005-05-06 Bioincept, Llc Pif peptides biologic activities, site of action, and the antibody to detect pif
US7723289B2 (en) * 2003-10-22 2010-05-25 Bioincept, Llc PIF tetrapeptides
US9737585B2 (en) 2011-03-02 2017-08-22 Bioincept, Llc Compositions and methods for treatment of intracellular damage and bacterial infection
WO2017039751A1 (en) 2015-08-28 2017-03-09 Bioincept, Llc Mutant peptides and methods of treating subjects using the same
EP2970496B1 (en) 2013-03-12 2018-07-18 Institute of Arthritis Research LLC Immunologically active polypeptide
AU2015343202A1 (en) * 2014-11-03 2017-05-25 Bioincept, Llc PIF binding as a marker for immune dysregulation
EP3341006A4 (en) 2015-08-28 2019-03-13 BioIncept LLC COMPOSITIONS AND METHODS FOR TREATING NERVE DAMAGE
CA3054366A1 (en) * 2017-02-22 2018-08-30 Bioincept, Llc Peptides and methods of treating dystrophy-related disorders using the same
US20240228620A1 (en) 2022-10-06 2024-07-11 Bicara Therapeutics Inc. Multispecific proteins and related methods

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US564003A (en) * 1896-07-14 chase
US6352694B1 (en) 1994-06-03 2002-03-05 Genetics Institute, Inc. Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
US5279941A (en) 1992-06-12 1994-01-18 Trustees Of The University Of Pennsylvania Determination of endometrial receptivity toward embryo implantation
AU5130793A (en) * 1992-09-17 1994-04-12 New York University Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites
US5646003A (en) 1994-03-23 1997-07-08 Barnea; Eytan R. Preimplantation factor
GB9406492D0 (en) 1994-03-31 1994-05-25 Isis Innovation Malaria peptides
US6489441B1 (en) * 1995-09-01 2002-12-03 The Salk Institute For Biological Studies Transcriptional co-repressor that interacts with nuclear hormone receptors
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
US6171591B1 (en) * 1997-12-08 2001-01-09 Pentamer Pharmaceuticals, Inc. Recombinant nodavirus compositions and methods
US20020004205A1 (en) 2000-03-30 2002-01-10 Consler Thomas G. Method of investigating functional molecular interactions and reagents for use therein
EP1355664A4 (en) 2001-01-04 2005-10-26 Vascular Biogenics Ltd METHODS INVOLVING MOLECULES ASSOCIATED WITH ATHEROSCLEROSIS PLATES AND COMPOSITIONS CONTAINING THESE MOLECULES FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
US8222211B2 (en) 2001-07-02 2012-07-17 Bioincept, Llc Methods of administering PIF agonist peptides and uses thereof
US7273708B2 (en) 2001-07-02 2007-09-25 Bioincept, Llc Assays for preimplantation factor and preimplantation factor peptides
WO2004053086A2 (en) 2002-12-06 2004-06-24 Epimmune, Inc. Plasmodium falciparum antigens and methods of use
US7156272B2 (en) * 2003-08-22 2007-01-02 Frank Dean Golf bag carrier for a motorcycle
US7723289B2 (en) 2003-10-22 2010-05-25 Bioincept, Llc PIF tetrapeptides
US7723290B2 (en) 2004-10-22 2010-05-25 Bioincept, Llc Compositions and methods for modulating the immune system
WO2005040196A2 (en) 2003-10-22 2005-05-06 Bioincept, Llc Pif peptides biologic activities, site of action, and the antibody to detect pif

Also Published As

Publication number Publication date
US20120009605A1 (en) 2012-01-12
DE60235011D1 (de) 2010-02-25
EP1404877A4 (en) 2007-07-11
NZ530723A (en) 2006-02-24
IL159671A (en) 2010-12-30
US7273708B2 (en) 2007-09-25
CA2490538A1 (en) 2003-01-16
EP1404877B1 (en) 2010-01-06
US7670852B2 (en) 2010-03-02
IL209509A0 (en) 2011-01-31
CN102875646B (zh) 2014-04-16
US20090011427A1 (en) 2009-01-08
CA2490538C (en) 2011-08-16
US20080305552A1 (en) 2008-12-11
US20050064520A1 (en) 2005-03-24
US20080305468A1 (en) 2008-12-11
CN1522306A (zh) 2004-08-18
CN103755787A (zh) 2014-04-30
EP1404877A2 (en) 2004-04-07
US20080293149A1 (en) 2008-11-27
US20080299677A1 (en) 2008-12-04
CN102875646A (zh) 2013-01-16
US8012700B2 (en) 2011-09-06
JP2005512953A (ja) 2005-05-12
IL209509A (en) 2012-08-30
US7695977B2 (en) 2010-04-13
IL159671A0 (en) 2004-06-01
IL209481A0 (en) 2011-01-31
IL209472A (en) 2014-02-27
IL209481A (en) 2014-02-27
CN102174079B (zh) 2013-09-11
JP4593106B2 (ja) 2010-12-08
AU2002320198B2 (en) 2007-10-04
CN103755787B (zh) 2016-05-18
IL194710A (en) 2014-06-30
US7678582B2 (en) 2010-03-16
CN100339388C (zh) 2007-09-26
MXPA04000151A (es) 2005-06-06
CN101059510A (zh) 2007-10-24
WO2003004601A3 (en) 2003-12-04
IL209472A0 (en) 2011-01-31
US7670850B2 (en) 2010-03-02
WO2003004601A2 (en) 2003-01-16
CN102174079A (zh) 2011-09-07
US7670851B2 (en) 2010-03-02
US20100197040A1 (en) 2010-08-05

Similar Documents

Publication Publication Date Title
IL209481A0 (en) Preimplantation factor peptide
ATE528648T1 (de) Verfahren zum nachweis antikörper-herstellender zellen
Lee et al. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation
WO2001049823A3 (en) Assays for detection of bacillus anthracis
ATE432947T1 (de) Menschliche antikörper als detektionsreagenzien
DE60133479D1 (de) Modifizierter tpo-agonisten antikörper
EP2455100A3 (en) Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof
MXPA05005288A (es) Inmunoanalisis no competitivo para analitos pequenos.
DE60228557D1 (de) Candida-nachweis
ATE478336T1 (de) Immunologische assays und antikörper für das anti-müller-hormon
CN105358976B (zh) 胰岛素测定法
ATE401338T1 (de) Von fibrin abgeleitete citrullinpeptide, die durch für rheumatoide arthritis spezifische autoantikörper erkannt werden, und deren verwendung
WO2021217140A3 (en) Specificity enhancing reagents for covid-19 antibody testing
WO2020005947A3 (en) Methods and kits for detection of 11-dehydro-thromboxane b2
WO2005106494A3 (en) Monoclonal antibodies, hybridomas, improved method for determining the protein ptx3 and kit for said determination
RU2009139650A (ru) Цепь с1 белка 2 промежуточного слоя хряща и его использование для дифференциальной диагностики остеоартрита от ревматоидного артрита и непатологических состояний
ATE188551T1 (de) Feststellung von antikörperproduktion
WO2005020891A3 (en) Monoclonal antibodies against ricin toxin and methods of making and using thereof
TR200100643T2 (tr) Yüksek-çekimli antikorlar
DE60002466D1 (de) Quantifizierungsverfahren für endotheliale mikroteilchen
EP1597579A4 (en) GENERIC PROCEDURE FOR LATEX AGGLUTINATION TESTS
WO2007056047A3 (en) Antibodies, assays and kits to quantitate cartilage destruction
AU2001250470A1 (en) Novel antibodies specifically identifying inactive psa, and uses thereof
ATE397218T1 (de) Epf-rezeptorassays, verbindungen und therapeutische zusammensetzungen
ATE478039T1 (de) Assays für amphetamin und methamphetamin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties